The revised JBI critical appraisal tool for the assessment of
risk of bias for randomized controlled trials

J 2023

The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials

BARKER, Timothy Hugh, Jennifer C STONE, Kim SEARS, Miloslav KLUGAR, Catalin TUFANARU et. al.

Basic information

Original name

The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials

Authors

BARKER, Timothy Hugh (guarantor), Jennifer C STONE, Kim SEARS, Miloslav KLUGAR (203 Czech Republic, belonging to the institution), Catalin TUFANARU, Jo LEONARDI-BEE, Edoardo AROMATARIS and Zachary MUNN

Edition

JBI Evidence Synthesis, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2023, 2689-8381

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30230 Other clinical medicine subjects

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 2.700 in 2022

RIV identification code

RIV/00216224:14110/23:00130598

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.11124/JBIES-22-00430

UT WoS

000945987900005

Keywords in English

critical appraisal tool; methodological quality; methodology; randomized controlled trial; risk of bias

Abstract

V originále

JBI recently began the process of updating and revising its suite of critical appraisal tools to ensure that these tools remain compatible with recent developments within risk of bias science. Following a rigorous development process led by the JBI Effectiveness Methodology Group, this paper presents the revised critical appraisal tool for the assessment of risk of bias for randomized controlled trials. This paper also presents practical guidance on how the questions of this tool are to be interpreted and applied by systematic reviewers, while providing topical examples. We also discuss the major changes made to this tool compared to the previous version and justification for why these changes facilitate best-practice methodologies in this field.

Links

LTC20031, research and development project

Name: Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic

Investor: Ministry of Education, Youth and Sports of the CR, INTER-COST

Citovat

BARKER, Timothy Hugh, Jennifer C STONE, Kim SEARS, Miloslav KLUGAR, Catalin TUFANARU, Jo LEONARDI-BEE, Edoardo AROMATARIS and Zachary MUNN. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evidence Synthesis. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2023, vol. 21, No 3, p. 494-506. ISSN 2689-8381. Available from: https://dx.doi.org/10.11124/JBIES-22-00430.

@article{2275823,
   author = {Barker, Timothy Hugh and Stone, Jennifer C and Sears, Kim and Klugar, Miloslav and Tufanaru, Catalin and LeonardiandBee, Jo and Aromataris, Edoardo and Munn, Zachary},
   article_location = {PHILADELPHIA},
   article_number = {3},
   doi = {http://dx.doi.org/10.11124/JBIES-22-00430},
   keywords = {critical appraisal tool; methodological quality; methodology; randomized controlled trial; risk of bias},
   language = {eng},
   issn = {2689-8381},
   journal = {JBI Evidence Synthesis},
   title = {The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials},
   url = {https://journals.lww.com/jbisrir/Fulltext/2023/03000/The_revised_JBI_critical_appraisal_tool_for_the.5.aspx},
   volume = {21},
   year = {2023}
}

TY  - JOUR
ID  - 2275823
AU  - Barker, Timothy Hugh - Stone, Jennifer C - Sears, Kim - Klugar, Miloslav - Tufanaru, Catalin - Leonardi-Bee, Jo - Aromataris, Edoardo - Munn, Zachary
PY  - 2023
TI  - The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials
JF  - JBI Evidence Synthesis
VL  - 21
IS  - 3
SP  - 494-506
EP  - 494-506
PB  - LIPPINCOTT WILLIAMS & WILKINS
SN  - 26898381
KW  - critical appraisal tool
KW  - methodological quality
KW  - methodology
KW  - randomized controlled trial
KW  - risk of bias
UR  - https://journals.lww.com/jbisrir/Fulltext/2023/03000/The_revised_JBI_critical_appraisal_tool_for_the.5.aspx
N2  - JBI recently began the process of updating and revising its suite of critical appraisal tools to ensure that these tools remain compatible with recent developments within risk of bias science. Following a rigorous development process led by the JBI Effectiveness Methodology Group, this paper presents the revised critical appraisal tool for the assessment of risk of bias for randomized controlled trials. This paper also presents practical guidance on how the questions of this tool are to be interpreted and applied by systematic reviewers, while providing topical examples. We also discuss the major changes made to this tool compared to the previous version and justification for why these changes facilitate best-practice methodologies in this field.
ER  -

BARKER, Timothy Hugh, Jennifer C STONE, Kim SEARS, Miloslav KLUGAR, Catalin TUFANARU, Jo LEONARDI-BEE, Edoardo AROMATARIS and Zachary MUNN. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. \textit{JBI Evidence Synthesis}. PHILADELPHIA: LIPPINCOTT WILLIAMS \&{} WILKINS, 2023, vol.~21, No~3, p.~494-506. ISSN~2689-8381. Available from: https://dx.doi.org/10.11124/JBIES-22-00430.

Detailed Information on Publication Record